Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-08-091037
Filing Date
2008-04-25
Accepted
2008-04-25 16:27:50
Documents
3
Period of Report
2007-12-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 391704
2 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex3111.htm EX-31.1.1 3207
3 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex3121.htm EX-31.2.1 3202
  Complete submission text file 0001193125-08-091037.txt   399518
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0101
Type: 10-K/A | Act: 34 | File No.: 000-21794 | Film No.: 08778009
SIC: 2836 Biological Products, (No Diagnostic Substances)